These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
821 related articles for article (PubMed ID: 9149018)
1. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Barth A; Craig PH; Silverstein MJ Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018 [TBL] [Abstract][Full Text] [Related]
2. Factors affecting axillary lymph node metastases in patients with T1 breast carcinoma. Markopoulos C; Kouskos E; Gogas H; Mandas D; Kakisis J; Gogas J Am Surg; 2000 Nov; 66(11):1011-3. PubMed ID: 11090007 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459 [TBL] [Abstract][Full Text] [Related]
4. Incidence and predictors of axillary metastasis in T1 carcinoma of the breast. Giuliano AE; Barth AM; Spivack B; Beitsch PD; Evans SW J Am Coll Surg; 1996 Sep; 183(3):185-9. PubMed ID: 8784309 [TBL] [Abstract][Full Text] [Related]
5. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature. Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092 [TBL] [Abstract][Full Text] [Related]
6. Prediction of lymph node status by analysis of prognostic factors and possible indications for elective axillary dissection in T1 breast cancers. Guarnieri A; Neri A; Correale PP; Lottini M; Testa M; Mariani F; Tucci E; Megha T; Cintorino M; Carli A Eur J Surg; 2001 Apr; 167(4):255-9. PubMed ID: 11354316 [TBL] [Abstract][Full Text] [Related]
7. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study. Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895 [TBL] [Abstract][Full Text] [Related]
8. Predictors of axillary lymph node metastasis in T1 breast carcinoma. Shoup M; Malinzak L; Weisenberger J; Aranha GV Am Surg; 1999 Aug; 65(8):748-52; discussion 752-3. PubMed ID: 10432085 [TBL] [Abstract][Full Text] [Related]
9. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335 [TBL] [Abstract][Full Text] [Related]
10. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor. Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485 [TBL] [Abstract][Full Text] [Related]
11. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible? Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Toyoshima S Eur J Surg; 2000 Aug; 166(8):610-5. PubMed ID: 11003428 [TBL] [Abstract][Full Text] [Related]
12. Is axillary lymph node dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla? Martelli G; Miceli R; De Palo G; Coradini D; Salvadori B; Zucali R; Galante E; Marubini E Cancer; 2003 Mar; 97(5):1156-63. PubMed ID: 12599220 [TBL] [Abstract][Full Text] [Related]
13. Biologic tumor markers, lymph node status, and decision about adjuvant chemotherapy for breast cancer. Velanovich V Am Surg; 1997 Apr; 63(4):330-3. PubMed ID: 9124752 [TBL] [Abstract][Full Text] [Related]
14. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast. Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492 [TBL] [Abstract][Full Text] [Related]
15. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302 [TBL] [Abstract][Full Text] [Related]
16. Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Tham YL; Sexton K; Kramer R; Hilsenbeck S; Elledge R Cancer; 2006 Aug; 107(4):696-704. PubMed ID: 16826579 [TBL] [Abstract][Full Text] [Related]
17. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast. Friedman NS; Freedman MD Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198 [TBL] [Abstract][Full Text] [Related]
18. Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis. Jinno H; Sakata M; Asaga S; Wada M; Shimada T; Kitagawa Y; Suzuki T; Nakahara T; Kitamura N; Kubo A; Mukai M; Ikeda T; Kitajima M Breast J; 2008; 14(6):551-5. PubMed ID: 19000054 [TBL] [Abstract][Full Text] [Related]
19. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma. Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455 [TBL] [Abstract][Full Text] [Related]
20. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery. Changsri C; Prakash S; Sandweiss L; Bose S Breast J; 2004; 10(5):392-7. PubMed ID: 15327491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]